6 semaglutide SUSTAIN-6 (NEJM 2016) enrolled 3,297 patients with T2DM at high CV risk and demonstrated that once-weekly reduced 3-point MACE by 26% (HR 0.74; p=0.02), driven by a striking 39% reduction in Post hoc analysis of SUSTAIN

GLP-1 receptor agonists in heart failure GLP-1 receptor agonists have demonstrated favorable cardiovascular effects in patients with T2DM and obesity as meta-analyses suggest a reduction in hospitalization for incident or new-onset HF of approximately 18%, alongside reductions in major adverse cardiovascular events [6, 14, 15]

Referral or promo codes found on third-party sites are generally unofficial or outdated

Bremetide A Proprietary PT-141 Formulation BMG offers PT-141 under the proprietary brand name Bremetide , which is available through both in-office visits and telemedicine consultations

Availability 50 States (verify in your state at signup) Starting Price $119/mo on the monthly plan